Prostate Cancer - Results from #20560

Multiparametric MRI and subsequent MR/ultrasound fusion-guided biopsy increase the detection of anteriorly located prostate cancers - Abstract May 14, 2014

Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer - Abstract May 14, 2014

Maximal testosterone suppression in prostate cancer-free vs total testosterone - Abstract May 14, 2014

Repackaging prostate cancer support group research findings: An e-KT case study - Abstract May 14, 2014

Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: A case report - Abstract May 14, 2014

Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: A feasibility study - Abstract May 12, 2014

The presence of a pituitary tumor in patients with prostate cancer is not a contraindication for leuprolide therapy - Abstract May 12, 2014

Changes in levels of prostate-specific antigen and testosterone following discontinuation of long-term hormone therapy for non-metastatic prostate cancer - Abstract May 12, 2014

The accuracy of magnetic resonance imaging in prostate cancer staging: A single-institution experience - Abstract May 12, 2014

Geometric distortion in diffusion-weighted MR imaging of the prostate-contributing factors and strategies for improvement - Abstract May 12, 2014

Multiparametric MRI identifies and stratifies prostate cancer lesions: Implications for targeting intraprostatic targets - Abstract May 12, 2014

Mobile application-based Seoul National University Prostate Cancer Risk Calculator: Development, validation, and comparative analysis with two Western risk calculators in Korean men - Abstract May 12, 2014

5-Alpha reductase inhibitors in active surveillance - Abstract May 12, 2014

High-intensity focused ultrasound as focal therapy of prostate cancer - Abstract May 12, 2014

Does race influence health-related quality of life and toxicity following proton therapy for prostate cancer? - Abstract May 12, 2014

Optimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus Panel - Abstract May 9, 2014

Rates of prostate-specific antigen testing for early detection of prostate cancer: A first comparison of German results with current international data - Abstract May 9, 2014

Registration of in vivo prostate MRI and pseudo-whole mount histology using Local Affine Transformations guided by Internal Structures (LATIS) - Abstract May 9, 2014

Diagnosing 'male' depression in men diagnosed with prostate cancer: The next step in effective translational psycho-oncology interventions? - Abstract May 9, 2014

Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators - Abstract May 9, 2014

Page 1029 of 1435